Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

Early Changes in Alpha-Fetoprotein Are a Useful Predictor of Efficacy of Atezolizumab plus Bevacizumab Treatment in Patients with Advanced Hepatocellular Carcinoma.

Teiji Kuzuya,Naoto Kawabe,Senju Hashimoto,Ryoji Miyahara,Akira Sawaki,Takuji Nakano,Kazunori Nakaoka,Hiroyuki Tanaka,Yohei Miyachi,Arisa Mii, Sayaka Kamejima,Takeshi Takahara,Yutaro Kato,Atsushi Sugioka,Yoshiki Hirooka

Oncology（2021）

Cited 17|Views20
No score
Abstract
Early changes in AFP might be useful for predicting the antitumor efficacy of atezolizumab plus bevacizumab in patients with advanced HCC. An AFP ratio of 1.4 or higher at 3 weeks might be an early predictor of refractoriness to atezolizumab plus bevacizumab therapy.
More
Translated text
Key words
Alpha-fetoprotein,Antitumor response,Atezolizumab,Bevacizumab,Des-γ-carboxy prothrombin,Hepatocellular carcinoma
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined